We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
-9.43%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
AUM
$2.7B
AUM Growth
-$296M
Cap. Flow
+$44.6M
Cap. Flow %
1.65%
Top 10 Hldgs %
8.27%
Holding
1,895
New
457
Increased
377
Reduced
454
Closed
575

Top Sells

Rank Stock Value
1
COR icon
Cencora
COR
+$22.3M
2
AMGN icon
Amgen
AMGN
+$21.9M
3
BABA icon
Alibaba
BABA
+$18.9M
4
SLB icon
SLB Ltd
SLB
+$18M
5
BMY icon
Bristol-Myers Squibb
BMY
+$14.8M

Sector Composition

Rank Sector Weight
1 Healthcare 13.76%
2 Technology 13.33%
3 Consumer Discretionary 12.45%
4 Industrials 11.02%
5 Financials 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWST icon
1276
Casella Waste Systems
CWST
$5.84B
$62K ﹤0.01%
10,774
-1,986
-16% -$12.1K
MXPT
1277
DELISTED
MaxPoint Interactive, Inc.
MXPT
$61K ﹤0.01%
+3,743
New +$101K
PACB icon
1278
Pacific Biosciences
PACB
$432M
$60K ﹤0.01%
16,469
-85,034
-84% -$416K
GMAN
1279
DELISTED
Gordmans Stores, Inc.
GMAN
$60K ﹤0.01%
17,259
-34,045
-66% -$155K
LTS
1280
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$58K ﹤0.01%
27,842
-3,100
-10% -$8.53K
ANFI
1281
DELISTED
AMIRA NATURE FOODS LTD
ANFI
$58K ﹤0.01%
+10,663
New +$83.6K
IRG
1282
DELISTED
Ignite Restaurant Group, Inc.
IRG
$58K ﹤0.01%
12,037
-8,428
-41% -$41.3K
KBIO
1283
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$58K ﹤0.01%
+30,626
New +$80.8K
SBS icon
1284
Sabesp
SBS
$18.7B
$56K ﹤0.01%
75,476
-915,004
-92% -$822K
VEDL
1285
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$55K ﹤0.01%
10,783
-771
-7% -$5.52K
LIOX
1286
DELISTED
Lionbridge Technologies
LIOX
$54K ﹤0.01%
+11,002
New +$61.4K
KGC icon
1287
Kinross Gold
KGC
$27.4B
$53K ﹤0.01%
31,057
TRQ
1288
DELISTED
Turquoise Hill Resources Ltd
TRQ
$52K ﹤0.01%
2,069
-1,410
-41% -$44.8K
KEM
1289
DELISTED
KEMET Corporation
KEM
$52K ﹤0.01%
28,482
-3,170
-10% -$6.34K
TAC icon
1290
TransAlta
TAC
$3.93B
$51K ﹤0.01%
11,052
ACER
1291
DELISTED
Acer Therapeutics Inc
ACER
$51K ﹤0.01%
+1,570
New +$55.4K
MCUR
1292
DELISTED
Macrocure Ltd.
MCUR
$50K ﹤0.01%
+14,968
New +$133K
DS
1293
DELISTED
Drive Shack Inc.
DS
$49K ﹤0.01%
11,226
SPRT
1294
DELISTED
support.com, Inc.
SPRT
$48K ﹤0.01%
14,487
-9,279
-39% -$35.4K
PQUE
1295
DELISTED
PETROQUEST ENERGY INC (DE)
PQUE
$48K ﹤0.01%
41,774
-2,900
-6% -$3.33K
GORO icon
1296
Goldgroup Mining Inc.
GORO
$151M
$47K ﹤0.01%
18,742
CVSL
1297
DELISTED
CVSL INC. COMMON STOCK
CVSL
$47K ﹤0.01%
+28,740
New +$45.5K
KALV
1298
DELISTED
KalVista Pharmaceuticals
KALV
$46K ﹤0.01%
+928
New +$79.1K
PERI icon
1299
Perion Network
PERI
$378M
$45K ﹤0.01%
7,154
-567
-7% -$4.18K
EYPT icon
1300
EyePoint Inc
EYPT
$988M
$43K ﹤0.01%
1,190
-90
-7% -$3.53K

Similar funds

A.R.T. Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, A.R.T. Advisors held 1,895 positions worth $2.7B, down 9.9% from $3B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

A.R.T. Advisors's Q3 2015 filing shows 457 new, 377 increased, 454 reduced and 575 closed positions. Its largest new stake was Teva Pharmaceuticals: 414,963 shares worth $23.4M. The largest sale was Cencora, an estimated $22.3M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

  • A.R.T. Advisors's largest Q3 2015 buy was Teva Pharmaceuticals: 414,963 shares worth $23.4M.
  • A.R.T. Advisors added most to Alphabet (Google) Class C in Q3 2015, an estimated $24.9M increase.
  • A.R.T. Advisors's biggest Q3 2015 reduction was Cencora, cutting an estimated $22.3M.
  • A.R.T. Advisors fully exited Alibaba in Q3 2015, selling an estimated $18.9M.
  • A.R.T. Advisors's ten largest holdings make up 8.3% of its $2.7B portfolio in Q3 2015.
  • A.R.T. Advisors opened 457 new positions and closed 575 in Q3 2015.
  • A.R.T. Advisors's portfolio value fell 9.9% quarter-over-quarter to $2.7B.

Based on A.R.T. Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.